Retinoblastoma can cause blindness, but it doesn’t always. The outcome depends heavily on the tumor’s size and stage at diagnosis, whether one or both eyes are affected, and which treatments are needed. With modern treatment, more than half of long-term survivors retain functional vision of 6/12 (20/40) or better in at least one eye, which is good enough to read, drive, and carry out daily activities without major limitations.
How Retinoblastoma Threatens Vision
Retinoblastoma is a cancer that starts in the retina, the light-sensing tissue at the back of the eye. As the tumor grows, it can destroy the retinal cells responsible for converting light into signals the brain interprets as sight. Small tumors may only affect a limited patch of the visual field, but larger ones can fill the interior of the eye or detach the retina entirely, wiping out useful vision in that eye.
The tumor can also grow into the optic nerve, the cable that carries visual information from the eye to the brain. Optic nerve invasion causes permanent vision impairment because the nerve tissue doesn’t regenerate. Beyond the threat to sight, tumor extension into the optic nerve is one of the most important warning signs for metastatic disease, meaning the cancer may have begun spreading beyond the eye.
When the Eye Can Be Saved
Not every child with retinoblastoma loses an eye. Doctors classify intraocular retinoblastoma into stages A through E based on tumor size, location, and whether cancer cells have seeded into the fluid inside the eye. Eye preservation rates track closely with these stages. In a recent study of 71 eyes, every eye at stages A, B, and C was saved. At stage D, about 71% of eyes were preserved. At stage E, the most advanced intraocular stage, only about 37% were saved. No eyes were preserved once the cancer had spread outside the eye.
The overall globe preservation rate across all stages was roughly 65%. For tumors still confined inside the eye, that number rose to about 72%. Children whose eyes were preserved scored significantly higher on functional vision assessments than those who had their eye surgically removed, with median functional vision scores of 92.5 versus 70 on a standardized parent questionnaire.
Eye-sparing treatments include chemotherapy delivered through the bloodstream, through a catheter threaded directly into the artery feeding the eye, or injected into the eye itself. Smaller tumors can also be treated with freezing therapy, heat therapy, or localized radiation using a small plaque placed on the eye. These approaches work best for discrete tumors that haven’t seeded into the eye’s interior fluid.
When Removal Is Necessary
Surgical removal of the eye (enucleation) is recommended when a large tumor fills the eye and there is little chance of restoring useful vision, when cancer has pushed into the front chamber of the eye, or when abnormal blood vessel growth has caused a painful type of glaucoma. It’s also the fallback when eye-sparing treatments fail to control the disease.
Unilateral retinoblastoma, affecting just one eye, is often diagnosed late because the child’s good eye compensates and parents don’t notice a problem. By the time it’s caught, the tumor may be massive, and upfront removal is the most common approach. Losing one eye eliminates depth perception on that side and narrows the visual field, but children adapt remarkably well and retain full vision in the remaining eye.
Bilateral Retinoblastoma and Total Blindness
When retinoblastoma affects both eyes, the stakes for vision are higher because treatment decisions must balance saving sight in at least one eye against controlling the cancer. The historical approach of automatically removing the worse eye has largely given way to evaluating each eye on its own merits and attempting to preserve as much vision as possible in both.
A review of 116 patients with bilateral disease found that 50% achieved visual acuity of 6/12 or better in at least one eye by age eight. Two patients managed that level of vision in both eyes. Total blindness from bilateral retinoblastoma is possible but not the most common outcome with modern treatment. The children at greatest risk are those diagnosed with advanced disease in both eyes simultaneously.
Vision Loss From Treatment Itself
Even when the eye is saved and the cancer is controlled, the treatments used can damage surrounding tissues and reduce visual quality over time. Radiation therapy, once a mainstay for retinoblastoma, carries well-documented risks. In one study of irradiated eyes, 20% developed cataracts (clouding of the lens) within an average of about two and a half years. Radiation damage to the retina itself occurred in 12% of treated eyes, typically appearing one to six years after treatment. Mild surface irritation of the cornea was observed in all irradiated eyes, though it was usually temporary.
Newer chemotherapy-based approaches have reduced the reliance on radiation, but they carry their own risks, including potential damage to the blood vessels that supply the retina. The shift toward delivering chemotherapy directly into the eye’s artery has improved tumor control while limiting some systemic side effects, though long-term visual data on these newer techniques continues to accumulate.
Long-Term Visual Outcomes for Survivors
For children who keep their eye, the range of visual outcomes is wide. A study of long-term survivors with preserved eyes found that 53% had distance vision of 6/12 or better, which is near-normal. Another 40% had moderate vision loss, falling between 6/12 and 6/60. Only 7% had severe impairment of 6/60 or worse. Where a child falls on this spectrum depends on tumor location (tumors near the center of the retina, called the macula, cause more vision loss), the number of treatments needed, and whether complications like retinal detachment occurred.
Children who lose one eye to enucleation and have no disease in the other eye generally grow up with excellent vision in everyday terms. They lose peripheral vision on the affected side and have reduced depth perception, which can affect activities like catching a ball or judging distances while driving, but most adapt during childhood and lead unrestricted lives.
Early Signs Parents Should Watch For
The single most important factor in preserving vision is catching the tumor early. The most common sign is leukocoria, a white reflection in the pupil that’s often first noticed in flash photographs where one eye glows white instead of the usual red. This appears in about 56% of cases at diagnosis. The second most common sign is strabismus, where the eyes appear misaligned or crossed, which happens when a tumor disrupts the part of the retina the child uses for focusing.
Early-stage tumors are small enough that they rarely cause noticeable vision changes, and young children can’t report blurry vision on their own. Routine eye exams in infancy, especially for children with a family history of retinoblastoma, catch tumors at stages where the eye can almost always be preserved and functional vision is most likely to be maintained.